Dengue’s dance: host immunity drives viral evolution
New research published in Science shows that as populations of people gain immunity to dengue, it drives evolutionary pressures that select for viral evolution—and newly susceptible hosts.
New research published in Science shows that as populations of people gain immunity to dengue, it drives evolutionary pressures that select for viral evolution—and newly susceptible hosts.
Two UF researchers are helping to determine if spreading a bacteria among mosquitoes can suppress the incidence of dengue infections in people.
UF researchers report an uncommon instance of a past infection in an adult by a dog coronavirus strain that also contained genetic features of a cat coronavirus.
A new model compares how various rapid antigen tests could be optimized with quarantine and surveillance efforts to reduce transmission of the SARS-CoV-2 virus that causes COVID-19.
A UF professor deploys unusual methods in the field to investigate bacteria that infect tomato and pepper crops.
Haiti's most recent earthquake caused damage to a building used by the University of Florida for past studies and projects. A retired UF staff member traveled to the island to help distribute aid. He shared the following photos with his colleagues.
Compared with the U.S., why are some countries less affected by COVID-19? A UF researcher leads a team looking for answers in Africa. “If we can learn what can protect us as a species, we could potentially be better prepared for the next pandemic," said Rhoel Dinglasan, professor of infectious diseases.
A team of UF researchers report genetic sequencing evidence showing how the gamma (P.1) variant rapidly replaced earlier lineages of the SARS-CoV-2 virus this past summer in Haiti. The outbreak occurred despite a relatively high level of immunity to SARS-CoV-2 within the population.
A new study found that 35% of all COVID-19 cases are asymptomatic. Children are most likely to lack symptoms, while the elderly are least likely.
A team of UF researchers has identified dozens of novel therapeutic targets for the development of antiviral therapies against COVID-19 and other coronaviruses that infect people.